About Stafford Jeffrey
Form D filings for 858 Therapeutics from 2021 to 2024 list Stafford Jeffrey as executive officer and director.
Stafford Jeffrey first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Stafford Jeffrey in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stafford Jeffrey works with at each company, as listed on that company's latest Form D.
858 Therapeutics, Inc. · Form D, Jul 11, 2024
JV
James Veal
Executive officer
JH
Jane Huang
Director
MM
Monal Mehta
Director
AB
Ali Behbahani
Director
KM
Katherine Bell-McGuinn
Executive officer
CO
Clare Ozawa
Director